And the isomers, unless specifically excepted, of the drugs in this Schedule whenever the existence of such isomers is possible within the specific chemical designation;
[And] the esters and ethers, unless appearing in another Schedule, of the drugs in this Schedule, whenever the existence of such esters or ethers is possible;
[And] the salts of the drugs listed in this Schedule, including the salts of the esters, ethers and isomers as provided above whenever the existence of such salts is possible.
For the calculation of estimates and statistics in accordance with the terms of the 1961 Convention, coca leaf preparations containing more than 0.1 per cent of Cocaine and made direct from Coca leaf should be considered to be Coca leaf (preparations).
CA: CDSA Schedule I Section 2 Subsection 2 Cocaine
Concentrate of poppy straw (the material arising when poppy straw has entered into a process for the concentration of its alkaloids when such material is made available in trade)
Morphine methobromide and Morphine-N-oxide and other pentavalent nitrogen morphine derivatives including in particular the Morphine-N-oxide derivatives, one of which is Codeine-N-oxide
[A]ll preparations made direct from opium are considered to be opium (preparations). If the preparations are not made direct from opium itself but are obtained by a mixture of opium alkaloids (as in the case, for example, with pantopon, omnopon and papaveretum) and should be considered as Morphine (preparations).
US: CSA Schedule II Section b Subsection 1 Item xvi Raw opium, Schedule III Section e Subsection 1 Item i Opium, Item v Opium and Schedule V Section c Subsection 5 Opium
US: [revoked] CSA Schedule III Section e Subsection 1 Opium
See also Narcotics Part 2 Section 4 Opium and Section 7 Opium
And the isomers, unless specifically excepted, of the drugs in this Schedule whenever the existence of such isomers is possible within the specific chemical designation;
[And] the salts of the drugs listed in this Schedule, including the salts of the isomers as provided above whenever the existence of such salts is possible.
US: CSA Schedule II Section b Subsection 1 Item i Codeine, Schedule III Section e Subsection 1 Item i Codeine, Item ii Codeine and Schedule V Section c Subsection 1 Codeine
US: CSA Schedule II Section c Subsection 7 Dihydrocodeine, Schedule III Section e Subsection 1 Item iii Dihydrocodeine and Schedule V Section c Subsection 2 Dihydrocodeine
US: CSA Schedule II Section b Subsection 1 Item iii Ethylmorphine, Schedule III Section e Subsection 1 Item iv Ethylmorphine and Schedule V Section c Subsection 3 Ethylmorphine
Preparations of Narcotic Drugs exempted from some provisions and which are included in Schedule III of the 1961 Convention
Acetyldihydrocodeine
Codeine
Dihydrocodeine
Ethylmorphine
Nicocodine
Nicodicodine
Norcodeine
Pholcodine
1.
Preparations of
Acetyldihydrocodeine,
Codeine,
Dihydrocodeine,
Ethylmorphine,
Nicocodine,
Nicodicodine,
Norcodeine and
Pholcodine
whencompoundedwithoneormoreotheringredients and containing not more than 100 milligrams of the drug per dosage unit and with a concentration of not more than 2.5 per cent in undivided preparations.
US: CSA Schedule II Section b Subsection 1 Item i Codeine, Schedule III Section e Subsection 1 Item i Codeine, Item ii Codeine and Schedule V Section c Subsection 1 Codeine
US: CSA Schedule II Section c Subsection 7 Dihydrocodeine, Schedule III Section e Subsection 1 Item iii Dihydrocodeine and Schedule V Section c Subsection 2 Dihydrocodeine
US: CSA Schedule II Section b Subsection 1 Item iii Ethylmorphine, Schedule III Section e Subsection 1 Item iv Ethylmorphine and Schedule V Section c Subsection 3 Ethylmorphine
Preparations of Propiram containing not more than 100 milligrams of Propiram per dosage unit andcompoundedwith at least the same amount of methylcellulose.
CA: CDSA Schedule I Section 12 Subsection 3 Propiram
Preparations of Dextropropoxyphene for oral use containing not more than 135 milligrams of Dextropropoxyphene base per dosage unit or with a concentrations of not more than 2.5 per cent in undivided preparations provided that such preparations do not contain any substance controlled under the 1971 Convention of Psychotropic Substances.
Preparations of Cocaine containing not more than 0.1 per cent of Cocaine calculated as Cocaine base; and Preparations of Opium or Morphine containing nor more than 0.2 per cent of Morphine calculated as anhydrous Morphine base andcompoundedwithoneormoreotheringredients and in such a way that the drug cannot be recovered by readily applicable means or in a yield which would constitute a risk to public health.
CA: CDSA Schedule I Section 2 Subsection 2 Cocaine
US: CSA Schedule II Section b Subsection 1 Item xvi Raw opium, Schedule III Section e Subsection 1 Item i Opium, Item v Opium and Schedule V Section c Subsection 5 Opium
US: [revoked] CSA Schedule III Section e Subsection 1 Opium
See also Narcotics Part 1 Section 1 Opium and Part 2 Section 7 Opium
Preparations of Difenoxin containing, per dosage unit, not more than 0.5 milligram of Difenoxin and a quantity of Atropine sulfate equivalent to at least 5 per cent of the dose of Difenoxin.
CA: CDSA Schedule I Section 3 Subsection 9 Difenoxin
Preparations of Diphenoxylate containing, per dosage unit, not more than 2.5 milligrams of Diphenoxylate calculated as base and a quantity of Atropine sulfate equivalent to at least 1 per cent of the dose of Diphenoxylate.
CA: CDSA Schedule I Section 3 Subsection 8 Diphenoxylate
US: CSA Schedule II Section b Subsection 1 Item xvi Raw opium, Schedule III Section e Subsection 1 Item i Opium, Item v Opium and Schedule V Section c Subsection 5 Opium
US: [revoked] CSA Schedule III Section e Subsection 1 Opium
See also Narcotics Part 1 Section 1 Opium and Part 2 Section 4 Opium
The stereoisomers of substances in Schedule I are also controlled, unless specifically excepted, whenever the existence of such stereoisomers is possible within the specific chemical designation.
Dronabinol (delta-9-Tetrahydrocannabinol) ((6aR,10aR)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol) and its stereochemical variants
CA: See Tetrahydrocannabinol, a more general designation which likely includes the delta-9 (Δ9) isomer specified here.
US: CSA Schedule III Section g Subsection 1 Dronabinol
CA: CDSA Schedule IV Section 1 Subsection 24 Secobarbital
US: CSA Schedule II Section e Subsection 5 Secobarbital, Schedule III Section c Subsection 1 Item ii Secobarbital and Subsection 2 Item ii Secobarbital
CA: CDSA Schedule IV Section 1 Subsection 20 Pentobarbital
US: CSA Schedule II Section e Subsection 3 Pentobarbital, Schedule III Section c Subsection 1 Item iii Pentobarbital and Subsection 2 Item iii Pentobarbital
Precursors and Chemicals Frequently used in the Illicit Manufacture of Narcotic Drugs and Psychotropic Substances under International Control (“Red List”)
Each Table II substance [with the exception of Hydrochloric acid and Sulphuric acid] includes the salts of that substance whenever such salts are possible.